Cytoplasmic sequestration of the tumor suppressor p53 by a heat shock protein 70 family member, mortalin, in human colorectal adenocarcinoma cell lines

Biochemical and Biophysical Research Communications

Volumn 423, Issue 2, 2012, Pages 411-416

  Gestl, Erin E ^a   Anne Bottger S ^a  

^a WEST CHESTER UNIVERSITY   (United States)

Author keywords

Colorectal adenocarcinoma; Heat shock proteins; Mortalin; Non mutational inactivation; Tumor suppressor

Indexed keywords

HEAT SHOCK PROTEIN 70; MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; PROTEIN MORTALIN; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CLINICAL EXAMINATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM;

ADENOCARCINOMA; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYTOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HSP70 HEAT-SHOCK PROTEINS; HT29 CELLS; HUMANS; IMMUNOPRECIPITATION; MITOCHONDRIAL PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84862905166     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.139     Document Type: Article

References (45)

1. Flamini G., Curigliano G., Ratto C., et al. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer A immunohistochemical analysis. Eur. J Can 1996, 32:802-806.
2. Bosari S., Viale G., Bossi P., et al. An independent prognostic indicator in colorectal adenocarcinomas. J. Natl. Cancer Inst. 1994, 86:681-687.
3. Miller C., Mohandas T., Wolf D., et al. Human p53 gene localized to short arm of chromosome 17. Nature 1986, 319:783-784.
4. Lassam N., From L., Kahn H. Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res. 1993, 53:2235-2238.
5. Hamelin R., Laurent-Puig P., Alschwang S., et al. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 1994, 106:42-48.
6. Soong R., Robbins P., Dix B., et al. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Hum. Pathol. 1996, 27:1050-1055.
7. Marks J., Davidoff A., Kerns B., et al. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res. 1991, 51:2979-2984.
8. Kupryjanczyk J., Thor A., Beauchamp R., et al. P53 and K-ras gene mutations in epithelial ovarian neoplasms. Cancer Res. 1993, 53:1-6.
9. Ebina M., Steinberg S., Muishine J., et al. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res. 1994, 54:2496-2503.
10. Starzynska T., Bromley M., Ghosh A., et al. Prognostice significance of p53 overexpression in gastric and colorectal carcinoma. Br. J. Cancer 1992, 66:558-562.
11. van Houten V., Tabor M., van den Brekel M., et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J. Pathol. 2002, 198:476-486.
12. Moll U., Riou G., Levine A. Two distinct mechanisms alter p53 in breast cancer: Mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA 1992, 89:7262-7266.
13. Dix B., Robbins P., Carello S., et al. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br. J. Cancer 1994, 70:585-590.
14. van den Heuvel S., van Laar T., The I., et al. Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation. J. Virol. 1993, 67:5226-5234.
15. Moll U., LaQuaglia M., Benard J., et al. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA 1995, 92:4407-4411.
16. Suzuki K., Ono T., Takahashi K. Inhibition of DNA synthesis by TGF-beta1 conincides with inhibition of phosphorylation and cytoplasmic translocation of p53 protein. Biochem. Biophys. Res. Commun. 1992, 183:1175-1183.
17. Takahashi T., Nau N., Chiba I., et al. P53: A frequent target for genetic abnormalities in lung cancer. Science 1989, 246:491-494.
18. Hendrick J., Hartl F. Molecular chaperone functions of heat-shock proteins. Annu. Rev. Biochem. 1993, 62:349-384.
19. Kampinga H., Craig E. The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat. Rev. Mol. Cell Biol. 2010, 11:579-592.
20. Akerfelt M., Morimoto R., Sistonen L. Heat shock factors: Integrators of cell stress, development and lifespan. Nat. Rev. Mol. Cell Biol. 2010, 11:545-555.
21. Kaul S., Deocaris C., Wadhwa R. Three faces of mortalin: A housekeeper, guardian and killer. Exp. Gerontol 2007, 42:263-274.
22. Deocaris C., Yamasaki K., Kaul S., et al. Structural and functional differences between mouse Mot-1 and Mot-2 proteins that differ in two amino acids. Ann. NY Acad. Sci. 2006, 1067:220-223.
23. Gupta R., Ramachandra N., Bowes T., et al. Unusual cellular disposition of the mitochondrial molecular chaperones Hsp60, Hsp70, and Hsp10. Novart. Fdn. Symp. 2008, 291:59-68.
24. Kaul S., Taira K., Pereira-Smith O., et al. Mortalin: Present and prospective. Exp. Gerontol 2002, 37:1157-1164.
25. Wadhwa R., Kaul S., Mitsui Y., et al. Differential subcellular distribution of mortalin in mortal and immortal mouse and human fibroblasts. Exp. Cell Res. 1993, 207:442-448.
26. Galigniana M., Harrell J., O'Hagen H., et al. Hsp90-binding immunophilins linkp53 to dynein during p53 transport to the nucleus. J. Biol. Chem. 2004, 279:22483-22489.
27. Giannakakou P., Sackett D., Ward Y., et al. P53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat. Cell Biol. 2000, 2:709-717.
28. Giannakakou P., Nakano M., Nicolaou K., et al. Enhance microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc. Natl. Acad. Sci. USA 2002, 99:10855-10860.
29. Yee K., Vousden K. Complicating the complexity of p53. Carcinogenesis 2005, 26:1317-1322.
30. Wadhwa R., Kaul S., Ikawa Y., et al. Identification of a novel member of mouse hsp70 family. Its association with cellular mortal phenotype. J. Biol. Chem. 1993, 268:6615-6621.
31. Wadhwa R., Takano S., Kamaljit K., et al. Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Int. J. Cancer 2006, 118:2973-2980.
32. Moll U., Ostermeyer A., Haladay R., et al. Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol. Cell Biol. 1996, 16:1126-1137.
33. Dundas S., Lawrie L., Rooney P., et al. Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J. Pathol. 2005, 205:74-81.
34. Kubbutat M., Jones S., Vousden K. Regulation of p53 stability by Mdm2. Nature 1997, 387:299-303.
35. Ford J., Hanawalt P. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem. 1997, 272:28073-28080.
36. Hoffman W., Biade S., Zilfou J., et al. Transcriptional repression of the anti-apoptotic surviving gene by wild type p53. J. Biol. Chem. 2002, 277:3247-3257.
37. Mineta H., Borg A., Dictor M., et al. P53 mutation, but not p53 overexpression, correlates with survival n head and neck squamous cell carcinoma. Br. J. Cancer 1998, 78:1084-1090.
38. Takano S., Wadhwa R., Yoshii Y., et al. Elevated levels of mortalin expression in human brain tumors. Exp. Cell Res. 1997, 237:38-45.
39. Yi X., Luk J., Lee N., et al. Association of mortalin (HSP9) with liver cancer metastasis and prediction for early tumor recurrence. Mol. Cell. Proteomics 2008, 7:315-325.
40. Mosser D., Morimoto R. Molecular chaperones and the stress of oncogenesis. Oncogene 2004, 23:2907-2918.
41. Czarnecka A., Campanella C., Zummo G., et al. Mitochondrial Chaperones in Cancer. Cancer Biol. Ther. 2006, 5:714-720.
42. Nagpal J., Jamoona A., Gulati N., et al. Revisiting the role of p53 in primary and secondary glioblastomas. Anticancer Res. 2006, 26:4633-4639.
43. Nikolaev A., Li M., Puskas N., et al. Parc: A cytoplasmic anchor for p53. Cell 2003, 112:29-40.
44. Zhu Z., Xu X., Graham M., et al. Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous call cancer cells in vitro. Mol. Pharm. 2010, 7:1283-1290.
45. Jmor F., Kalirai H., Taktak A., et al. HSP-27 protein expression in uveal melanomas: Correlation with predicted survival. Acta Ophthalmol 2010, 88:1-7.